AMERICAN ACADEMY OF NEUROLOGY (AAN) MEETING 2016 INTERVIEW WITH DR REBECCA SPAIN – OREGON HEALTH AND SCIENCES UNIVERSITY (OHSU), VA PORTLAND HEALTH CARE SYSTEM BD: Brett Drummond,...

AMERICAN ACADEMY OF NEUROLOGY (AAN) MEETING 2016 INTERVIEW WITH DR TOMAS KALINCIK – MELBOURNE BRAIN CENTRE, ROYAL MELBOURNE HOSPITAL BD: Brett Drummond, MStranslate TK: Dr Tomas Kalincik,...

A small, Phase II clinical trial has shown that a common over the counter antihistamine, called clemastine fumarate, has the ability to partially reverse damage to the optic nerve in people with multiple...

Research Summary: Conditioned Medium from the Stem Cells of Human Exfoliated Deciduous Teeth Ameliorates Experimental Autoimmune Encephalomyelitis The background Current MS therapies mostly work to suppress...

Research Summary: Regulation of prefrontal cortex myelination by the microbiota The Background In recent times, there has been an increasing focus placed on the role that the gut microbiome (composed of...

Research Summary: Rituximab versus fingolimod after natalizumab in multiple sclerosis patients The background Whilst natalizumab has emerged as a potent treatment for multiple sclerosis (MS), it is also...

An MStranslate Opinion Piece When I was younger, I was cast in the role of Robin Hood in a school musical.  I robbed from the rich to give to the poor.  My delusions of becoming acting royalty resulted in...

Research Summary: Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis The background When developing new therapies, an ideal outcome is that they will be able to be...

Research Summary: Cutting Edge: Integrin a4 is required for regulatory B cell control of experimental autoimmune encephalomyelitis The background For a long time, multiple sclerosis was regarded as an...

Research Summary: Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training The background Brain derived neurotrophic factor (BDNF) is a protein that...